Additionally, we demonstrate that HK1 is transcriptionally regulated by ZBTB10, indicating that targeting ZBTB10 or HK1 may be a potential approach for treating laryngeal cancer patients with OSA. This evidence concerns the gene ZBTB10 and obstructive sleep apnea syndrome.